TSMHT
TECH icon

Thurston Springer Miller Herd & Titak’s Bio-Techne TECH Stock Holding History

Thurston Springer Miller Herd & Titak’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.41K Hold
20
– – ﹤0.01% 1134
2026
Q1 		$1.04K Hold
20
– – ﹤0.01% 1246
2025
Q4 		$1.18K Buy
+20
New +$1.22K ﹤0.01% 1276
2025
Q3 		– Sell
-389
Closed -$20K – 1272
2025
Q2 		$20K Buy
389
+291
+297% +$14.6K ﹤0.01% 938
2025
Q1 		$5.75K Buy
+98
New +$6.64K ﹤0.01% 1245

Other funds holding TECH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Thurston Springer Miller Herd & Titak's TECH Position: Q2 2026 in Review

Thurston Springer Miller Herd & Titak held its Bio-Techne (TECH) position steady in Q2 2026 at 20 shares worth $1.41K. The position accounts for ﹤0.01% of the portfolio, ranked #1134.

Thurston Springer Miller Herd & Titak first reported a position in TECH in Q1 2025 and has held it in 5 quarters since. The position peaked at $20K in Q2 2025. 595 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • Thurston Springer Miller Herd & Titak held 20 shares of Bio-Techne worth $1.41K as of Q2 2026.
  • Thurston Springer Miller Herd & Titak left its Bio-Techne share count unchanged in Q2 2026.
  • Bio-Techne made up ﹤0.01% of Thurston Springer Miller Herd & Titak's portfolio in Q2 2026, its #1134 holding.
  • Thurston Springer Miller Herd & Titak first reported a position in Bio-Techne in Q1 2025 and has held it in 5 quarters since.
  • Thurston Springer Miller Herd & Titak's Bio-Techne position peaked at $20K in Q2 2025.
  • 595 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Thurston Springer Miller Herd & Titak's 13F filing for Q2 2026, filed 8 Jul 2026.